HeartSciences, Inc. (HSCS)
4.30
+0.41
(+10.54%)
USD |
NASDAQ |
Oct 02, 16:00
4.06
-0.24
(-5.58%)
Pre-Market: 08:00
HeartSciences Debt to Equity Ratio : -1.970 for July 31, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| July 31, 2026 | -1.970 |
| April 30, 2026 | 17.41 |
| January 31, 2026 | 1.458 |
| October 31, 2025 | 0.2095 |
| July 31, 2025 | 0.6198 |
| April 30, 2025 | 14.55 |
| January 31, 2025 | 1.672 |
| October 31, 2024 | 0.7228 |
| July 31, 2024 | 0.1706 |
| April 30, 2024 | 0.1416 |
| January 31, 2024 | 0.1227 |
| Date | Value |
|---|---|
| October 31, 2023 | -1.211 |
| July 31, 2023 | -3.046 |
| April 30, 2023 | 6.790 |
| January 31, 2023 | -6.511 |
| October 31, 2022 | 1.580 |
| July 31, 2022 | 0.4127 |
| April 30, 2022 | -1.018 |
| January 31, 2022 | -1.311 |
| October 31, 2021 | |
| July 31, 2021 | |
| April 30, 2021 | -1.612 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Accuray, Inc. | 4.502 |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 0.6797 |
| Neogen Corp. | 0.388 |
| Orthofix Medical, Inc. | 0.6102 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.737M |
| Total Liabilities (Quarterly) | 5.770M |
| Shareholders Equity (Quarterly) | -2.033M |
| Current Ratio | 0.1219 |
| Net Debt Paydown Yield | -2.39% |